Zeke Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,329
| Closed | -$563K | – | 506 |
|
|
2022
Q1 | $563K | Buy |
10,329
+1,579
| +18% | +$86.1K | 0.03% | 210 |
|
|
2021
Q4 | $482K | Buy |
8,750
+904
| +12% | +$49.8K | 0.03% | 157 |
|
|
2021
Q3 | $375K | Sell |
7,846
-400
| -5% | -$19.1K | 0.02% | 181 |
|
|
2021
Q2 | $410K | Sell |
8,246
-208
| -2% | -$10.3K | 0.03% | 167 |
|
|
2021
Q1 | $377K | Buy |
8,454
+116
| +1% | +$5.17K | 0.03% | 161 |
|
|
2020
Q4 | $384K | Sell |
8,338
-2,172
| -21% | -$100K | 0.03% | 150 |
|
|
2020
Q3 | $494K | Sell |
10,510
-924
| -8% | -$43.4K | 0.06% | 109 |
|
|
2020
Q2 | $583K | Sell |
11,434
-74
| -0.6% | -$3.77K | 0.11% | 90 |
|
|
2020
Q1 | $545K | Sell |
11,508
-35,530
| -76% | -$1.68M | 0.15% | 81 |
|
|
2019
Q4 | $2.76M | Sell |
47,038
-5,357
| -10% | -$315K | 0.23% | 86 |
|
|
2019
Q3 | $2.8M | Sell |
52,395
-158
| -0.3% | -$8.43K | 0.25% | 83 |
|
|
2019
Q2 | $2.63M | Buy |
52,553
+1,260
| +2% | +$63K | 0.25% | 80 |
|
|
2019
Q1 | $2.68M | Buy |
51,293
+13,961
| +37% | +$729K | 0.25% | 81 |
|
|
2018
Q4 | $1.78M | Buy |
+37,332
| New | +$1.78M | 0.17% | 98 |
|